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Abstract
Background: There is limited information about the potential associations of
multiple sclerosis (MS) and commonly used household chemicals. Methods:
We performed a case-control study of exposures to common household chemi-
cals during childhood in children with MS and healthy pediatric controls.
Exposures to household products were collected from a comprehensive ques-
tionnaire (http://www.usnpmsc.org/Documents/EnvironmentalAssessment.pdf)
completed by parents at the time of enrollment in the study. Cases included
children diagnosed with MS or clinically isolated syndrome with at least two
silent T2 bright lesions on MRI, recruited within 4 years of disease onset from
16 pediatric MS clinics in the USA. Multivariate analyses using logistic regres-
sion were adjusted for possible confounders including age, sex, race, ethnicity,
mother’s highest level of education, and urban versus rural living. Results:
Questionnaire responses to household chemicals were available for 312 eligible
cases (median age 15.7 years, 63% girls) and 490 healthy controls (median age
15.0, 57% girls). Exposure to rodenticides (odds ratio [OR] 2.10, 95% confi-
dence interval [CI] 1.35–3.26, P ≤ 0.001), weed control agents (OR 1.99, 95%
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CI 1.36–2.92, P ≤ 0.001) and products for plant/tree disease control (OR 2.72,
95% CI 1.54–4.82, P ≤ 0.001) anytime during childhood were associated with
an increased risk for pediatric-onset MS in adjusted and multiple comparisons
analyses. Conclusions: Our findings suggest that exposure to specific household
chemicals during early childhood is associated with the risk of developing pedi-
atric-onset MS. Future studies are needed to elucidate a causal relationship and
the exact agents involved.
Introduction
Multiple sclerosis (MS) is an immune-mediated disease
that causes demyelination of the central nervous system.
Of the estimated 2.3 million people living with MS
worldwide, ~5% had a pediatric onset.1
Autoimmune diseases, including MS, occur as a result
of complex interactions between genetic and environmen-
tal factors. While some environmental factors such as
remote exposure to Epstein-Barr virus infection, vitamin
D deficiency, and exposure to cigarette smoking have
been associated with MS, these factors only partially
explain the risk.2–5 Studies also identified toxic exposures
including organic solvents to be associated with MS in
adults.6 Organic solvents, which are chemical compounds
used routinely in commercial industries, can alter cellular
proliferation, apoptosis and tissue-specific functions, and
chronic exposure may lead to deposits in an organ.7–9
Self-proteins that are modified by organic solvents may
become immunogenic, and trigger an inflammatory cas-
cade with resulting tissue injury.10 However, exposure to
a chemical toxin alone may be insufficient to cause a dis-
ease such as MS, and more likely the environmental expo-
sure become relevant in a genetically-susceptible
individual.
We have previously reported that pesticide exposures
in the household in the perinatal period were associated
with increased risk of pediatric-onset MS.11 Our goal was
to identify associations between exposures to household
chemicals during childhood and the risk of pediatric-
onset MS, and annualized relapse rate in those with the
disease.
Methods
Study design
We performed a cross-sectional analysis of data collected
from a large on-going case control study of risk factors in
pediatric MS (1R01NS071463, PI Waubant) to evaluate
potential associations between MS and history of expo-
sures to common household chemicals. An IRB or regio-
nal review board has approved the use of human subjects
for this study and written informed consent was obtained
from guardians of patients participating in the study at
all study sites.
Participants
Pediatric-onset MS or clinically isolated syndrome (CIS)
cases with at least two silent MRI demyelinating lesions,
with onset before 18 years, seen within 4 years of disease
onset were enrolled (between November 1 2011 and July
1 2016) from 16 pediatric MS centers in the United
States. These centers are tertiary referral centers, but also
serve regional patients from all socioeconomic groups.
Diagnosis for cases was ascertained by a panel of at least
two experts in pediatric MS. Frequency matched healthy
controls younger than 20 years were recruited from the
pediatric general and subspecialty clinics at participating
institutions during the same period of time as the cases.
Controls were matched with patients in windows for age
at enrollment: 3–10, 11–14, and 15–19 years. Pairwise
matching was not used as for our cohort it would have
resulted in a substantial loss of the sample.
Inclusion criteria for controls included absence of any
autoimmune disease, except asthma and eczema, and no
parent with MS. Controls with family history of MS were
excluded to allow evaluation of genetic risk factors of
pediatric MS as part of a larger study. Data were collected
via an environmental questionnaire completed by a
parent or legal guardian.
Questionnaire
Parents completed a comprehensive environmental ques-
tionnaire (http://www.usnpmsc.org/Documents/Environ
mentalAssessment.pdf). Questions included prior
exposures and the timing of exposures to:
• mothballs, crystals, bars, or synthetic closet fresheners,
• antibacterial soap or other antibacterial hand products,
• professional pest control or extermination service prod-
ucts,
• ant, fly, or cockroach control products,
• rat, mouse, gopher, or mole control products,
• insect repellent for ticks or mosquitos,
• slug or snail bait,
• weed control products,
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• plant/tree insect or disease control products,
• paint, stains, or lacquers,
• adhesives or petroleum products,
• indoor foggers for insect control,
• sprays, dusts, powders, or skin applications for fleas or
ticks, or flea or tick collars.
The questions were specific of various times of expo-
sure: 3 months before pregnancy, during pregnancy,
while breastfeeding, first year of life, age 1–5 years, 6–
10 years, 11–15 years, and greater than 16 years. The
questionnaires asked about the indirect or passive expo-
sure, ever been exposed, frequency, duration, and timing
of the exposure. Example of the indirect exposure ques-
tionnaire included “Did someone in the household ever
use a professional pest control or extermination service?
If yes, please provide the names of the products with the
time frame the products were used. Please choose one of
the following options for how often and who used the
product and place the letters in the corresponding
boxes”. An example question for passive exposure
included “Did the biological mother or main mother
figure/guardian smoke from the time the child was
1–5 years of age?”.
As we have previously reported associations related to
before and during pregnancy, we have excluded exposures
occurring 3 months before or during the pregnancy.11
For cases, only toxic exposures that took place before
disease onset were included. Otherwise, the case was
considered unexposed.
Statistical analysis
Demographics characteristics were compared with the
Kruskal–Wallis test and chi-squared test as appropriate.
Household chemical exposures were compared between
the cases and controls using a chi-squared test. Multi-
variable logistic regression models adjusted for age, sex,
race, ethnicity, mother’s education (as a proxy for
socioeconomic), and urban versus rural living were used
to test for significant differences between cases and con-
trols. P-values of less than 0.05 were considered signifi-
cant. Odds ratios were calculated with 95% confidence
intervals. The household chemicals were put into both
adjusted and unadjusted models.Annualized relapse rate
(AAR) was modeled as the number of events over the
total follow-up time period in years. A negative bino-
mial regression model was used for AAR and was
adjusted for age at disease onset, sex, race, and ethnic-
ity. Significant differences in the relapse rates were
assessed using likelihood ratio tests. Analyses were con-
ducted using SAS software, version 9.4 (SAS Institute
Inc., Cary, NC).
Results
Completion of questionnaires
Of 561 cases and 644 controls screened up to 1 July 2016,
326 eligible cases and 506 healthy controls completed the
full questionnaires. Among them, 312 cases (95%, median
age 15.7 years, 63% girls) and 490 controls (96%, median
age 15.0 years, 57% girls) completed the household chem-
icals exposure questionnaire section. (Fig. 1).
Baseline characteristics
As shown in Table 1 individuals of Hispanic ethnicity
were more frequent in cases than in controls (30% vs.
19%, P < 0.001). Controls relative to cases had a higher
proportion of mothers with higher level of education
(Bachelor’s or graduate degree 48% vs. 32%, P < 0.001).
A higher percentage of controls had a residence only in
an urban ZIP code compared to cases (44% vs. 35%,
P = 0.010). Other baseline characteristics were similar in
both groups.
Household chemicals and risk of pediatric
MS
As shown in Table 2, based on the unadjusted analysis,
MS cases relative to Controls had a higher exposure to
rodenticides (rat, mouse, gopher, or mole control prod-
ucts) (P = 0.001), weed control products (P = 0.012),
plant/tree insect or disease control products (P = 0.031)
and indoor foggers for insect control (P = 0.030). In
addition, a multiple regression analysis adjusting for the
covariants (age, sex, race, ethnicity, mother’s highest level
of education, urban versus rural living) showed among
MS cases versus controls a higher frequency of exposure
to rodenticides (odds ratio [OR] 2.10, 95% confidence
interval [CI] 1.35–3.26, P ≤ 0.001), insect repellent (OR
1.47, 95% CI 1.05–2.06, P = 0.025), weed control agents
(OR 1.99, 95% CI 1.36–2.92, P ≤ 0.001), products for
plant/tree disease control (OR 2.72, 95% CI 1.54–4.82,
P ≤ 0.001), adhesive and petroleum products (OR 1.45,
95% CI 1.01–2.08, P = 0.044) and indoor foggers for
insect control (OR 1.70, 95% CI 1.04–2.79, P = 0.035)
anytime during childhood. On multiple comparisons,
insect repellent, adhesives, and indoor foggers were no
longer significant based on their adjusted P P -values
using the false discovery rate method. The rodenticides,
weed control agents, and plant/tree disease control prod-
ucts were still significantly associated with risk of develop-
ing pediatric–onset MS. To rule out any potential
heterogeneity in associations of household chemical expo-
sures between the subjects who met MS criteria
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Screened
Case 561
Control 644
Total 1205
Failed 
screening 
criteria
17
Did not 
consent / met 
exclusion 
criteria
135
Case did not 
meet criteria 
for MS/CIS
4
Analysis Population
Case 446
Control 603
Total 1049
Adequate 
data entry in 
registry
1027
Inadequate 
data entry in 
registry
22
Questionnaire received
Case 326
Control 506
Total 832
No questionnaire received
Case 109
Control 86
Total 195
No household chemical 
exposure response
Case 14
Control 16
Total 30
Household chemical exposure 
response
Case 312
Control 490
Total 802
Figure 1. Case and control enrollment and inclusion.
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(McDonald 2010) and those who were CIS, we performed
sensitivity analysis for the adjusted models with only MS
patients by excluding those with most recent diagnosis
with CIS at the time of last visit and found the results
were unchanged. Given the wide recruitment window, we
have also looked into the possibility of heterogeneity in
cas/control characteristics over time and we have not seen
any evidence of that. In addition, we did not see any
meaningful change in results, when BMI was added in the
model.
Exposure to other household chemicals such as moth-
balls, crystals, bars, or synthetic closet fresheners, antibac-
terial soap or other antibacterial hand products,
professional pest control or extermination service prod-
ucts, ant, fly, or cockroach control products, slug or snail
bait, dusts, powders, or skin applications for fleas or ticks,
or flea or tick collars, were not associated with risk of MS
in children. Specifically, unlike in adult onset-MS, expo-
sures to organic solvents (paint, stains, or lacquers) were
not associated with an increased risk for pediatric- onset
MS.
Household chemicals and ARR in children
with MS
To determine the association between exposure to house-
hold chemicals and ARR, and to maximize the likelihood
of seeing an effect, we performed a subgroup analysis of
only cases who had neurological evaluation at a pediatric
MS center within 3 years of their first demyelinating
event and in whom prospective relapse documentation
was complete at the time of last visit (n = 271). After
adjusting for age at onset, sex, race and ethnicity, expo-
sure to mothballs, crystals, bars, or synthetic closet fresh-
eners were associated with increased ARR (P = 0.008).
No other domestic exposures were associated with relapse
rate (Table 3).
Discussion
Our findings suggest that exposures to rodenticides, weed
control products, plant/tree insect or disease control
products during childhood are associated with pediatric-
onset MS. These results are consistent with our prior
observations linking pediatric MS onset to certain envi-
ronmental exposures just prior to pregnancy and through
the first year of life.11
An ecological study investigating the potential link
between environmental pesticide exposures and various
neurologic and psychiatric conditions in southern Spain,
reported an increased prevalence of adult MS in areas of
high, compared to low, agricultural pesticide exposure
(OR 1.23, 95% CI 1.05–1.43).12 Other environmental
exposures, such as heavy metals and solvents, exhibited a
stronger association with MS.12
Pesticides and other environmental toxic agents have
been associated with neurodegeneration possibly due to
effects of reactive oxygen species in nerve tissue, based on
animal studies. Organophosphates inhibit acetyl-
cholinesterase leading to excessive acetylcholine, activation
of glutamatergic neurons, and drive excitotoxicity and
neuronal cell death.12 A proposed mechanism linking
environmental toxins to MS is the activation of the
immune system by toxic chemicals leading to destruction
of oligodendrocytes.12 Alternately, environmental toxins
may have an indirect effect by modifying native proteins,
such that they are misidentified as foreign proteins, set-
ting off a cascade of inflammation and CNS injury.10
However, it has also been suggested that the toxic effect
Table 1. Baseline characteristics between cases and controls.
Subject status as case or control
P-value
Control
(N = 490) Case (N = 312)
Childs age at
disease onset
(median [IQR])
- [-, -] 15.0 [12.6, 16.4]
Childs age at
consent (median
[IQR])
15.0 [12.1, 17.4] 15.7 [13.6, 17.3] 0.061
Sex
Male 213 (43%) 117 (38%) 0.092
Female 277 (57%) 195 (63%)
Race
White 323 (68%) 206 (71%) 0.642
Black 81 (17%) 45 (15%)
Asian 28 (6%) 12 (4%)
Other 42 (9%) 28 (10%)
Ethnicity
Hispanic or Latino 92 (19%) 93 (30%) <0.0012
Not Hispanic or
Latino
387 (79%) 207 (66%)
Unknown or Not
Reported
11 (2%) 12 (4%)
Biological mothers highest level of education
None 27 (6%) 36 (12%) <0.0012
High School or
Associate’s
215 (47%) 163 (56%)
Bachelor’s or
Graduate
220 (48%) 94 (32%)
Residence ZIP code
only in an urban
area
No 260 (56%) 190 (65%) 0.0102
Yes 207 (44%) 102 (35%)
1Kruskal–Wallis test.
2Chi-squared test of no association.
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influences the appearance of autoimmune diseases like
MS, only in subjects who are genetically susceptible.13
Many environmental exposures have been explored as
potential risk factors for the development of MS but
exposures to household chemicals have not been studied
in detail. Exposure to organic solvents, which are often
used in commercial industries, have been reported to be
associated with an increased risk of adult MS (OR 1.53,
95% CI 1.03–2.29).6,10 However, in our study, childhood
exposure to paint, stains, or lacquers, which generally
contain organic solvents, was not associated with
increased risk of pediatric onset-MS. It is possible that
the amount and duration of exposure may be important,
as children generally do not get exposed to organic sol-
vents for a large quantity or a prolonged period of time.
Our study also does not preclude an association with
adult-onset MS.
Investigating occupational exposures may also elucidate
environmental associations and risk for MS. We previ-
ously reported increased risk of pediatric-onset MS in
participants whose fathers had worked in agricultural
occupations during the perinatal period.11 While data are
limited, an Australian case-control study of adults showed
that some occupational exposures were strongly associated
with increased risk of a first CNS demyelinating event,
itself often followed by MS.14 For women, there was an
increased risk for a first CNS demyelinating event with
≥10 years of exposure to livestock (adjusted odds ratio
[AOR] 2.78, 95% CI 1.22–6.33), as well as farming for
≥6 years (AOR 2.00, 95% CI 1.23–3.25). These findings
were not seen among men. Interestingly, the risk of
farming was associated with exposure to livestock, rather
than pesticides used on farms. Further, a large Norwegian
study examining offshore workers in the petroleum indus-
try, who are exposed to chemicals such as organic sol-
vents, mineral oils, and other hydrocarbons, did not find
an increased risk for MS.15
More work needs to be done in animals to see if expo-
sure to any of these household chemicals can induce CNS
inflammation and demyelination. In fact, toxins can induce
demyelination in animal models of MS such as lysolecithin
and cuprizone. Lysolecithin is an activator of phospholi-
pase A2 and cuprizone is a copper chelator. However,
toxin-induced demyelination models do not replicate all
the biological characteristics of MS, and animals remyeli-
nate when cuprizone is removed from their diet.16
Studies like ours that investigate environmental risk
factors for MS in isolation should be interpreted with
caution, as the combination of environmental and genetic
factors together contribute to MS risk.17,18 In addition,
we did not adjust for other potential confounding vari-
ables such as sun exposure, vitamin D intake, and infec-
tious mononucleosis history in this study. However, we
have collected and analyzed some of these variables sepa-
rately as risk factors for pediatric MS in our different
studies17,19 and our analyses adjusted for BMI. Due to
onset in childhood, most individuals do not have a prior
history of mononucleosis and this data are not available.
Other limitations of our study include possible recall
and sampling bias or possible exposure misclassification.
However, recall bias is unlikely in most scenarios as peo-
ple tend to remember specifics such as using professional
Table 2. Toxic exposure analyses.
Unadjusted Adjusted2
Control
(N = 490)
Case
(N = 312)
P-
value
Odds ratio (95%
CI)
P-
value
Mothballs, crystals, bars, or synthetic closet fresheners 31 (6%) 26 (9%) 0.181 1.70 (0.90, 3.18) 0.10
Antibacterial soap or other antibacterial hand products 266 (55%) 152 (52%) 0.401 1.02 (0.73, 1.43) 0.91
Professional pest control or extermination service 97 (20%) 66 (22%) 0.421 1.31 (0.87, 1.96) 0.19
Ant, fly, or cockroach control products 192 (40%) 126 (43%) 0.341 1.33 (0.95, 1.86) 0.10
Rat, mouse, gopher, or mole control products 60 (12%) 62 (21%) 0.0011 2.10 (1.35, 3.26) <0.001
Insect repellent for ticks or mosquitos 228 (47%) 149 (50%) 0.371 1.47 (1.05, 2.06) 0.025
Slug or snail bait 17 (3%) 10 (3%) 0.931 0.94 (0.39, 2.14) 0.89
Weed control products 123 (25%) 99 (33%) 0.0121 1.99 (1.36, 2.92) <0.001
Plant/tree insect or disease control products 34 (7%) 34 (11%) 0.0311 2.72 (1.54, 4.82) <0.001
Paint, stains, or lacquers 229 (48%) 146 (50%) 0.551 1.29 (0.91, 1.83) 0.16
Adhesives or petroleum products 165 (34%) 109 (37%) 0.301 1.45 (1.01, 2.08) 0.044
Indoor foggers for insect control 42 (9%) 40 (13%) 0.0301 1.70 (1.04, 2.79) 0.035
Sprays, dusts, powders, or skin applications for fleas or ticks, or flea or
tick collars
130 (27%) 79 (27%) 0.961 1.25 (0.86, 1.81) 0.25
1Chi-squared test of no association.
2Adjusted for age, sex, race, ethnicity, mother’s highest level of education, and urban only.
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exterminator services and obvious occupational exposures
to certain products administered by self or others. Sam-
pling bias is unlikely as we adjusted urban versus rural
living using the zip codes. As our study is an exploratory
study, these limitations were unavoidable but we will
address these in future studies. We also plan to develop
more detailed environmental questionnaires, including
the dose, duration, age, and timing of the exposures to
the onset of the disease to help us determine whether
observed associations in this study were genuine or not.
A major strength of our study is the large sample size
with cases enrolled all over the US, and high response
rates. The large sample size enabled us to adjust the anal-
yses for multiple potential confounders. Another major
strength is our focus on the development of pediatric-,
rather than adult-onset MS, leading to a much shorter
time lag between exposure and MS onset and associated
with better recall of childhood exposures. In addition, our
cases were ascertained by pediatric MS specialists, and
controls were enrolled at the same institutions than cases.
Conclusions
This study reveals an association between prior exposures
to a few common household chemicals during early child-
hood and an increased risk for pediatric-onset MS. Fur-
ther research is necessary to confirm these findings,
determine whether the association is causal, and identify
the specific active ingredients associated with the
increased risk of MS. Finally, the study of gene-
environment interactions may help elucidate the biologi-
cal processes underlying the association we report.
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